Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone - Concepedia

Concepedia

Publication | Closed Access

Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

954

Citations

38

References

2012

Year

Nathalie A. Johnson, Graham W. Slack, Kerry J. Savage, Joseph M. Connors, Susana Ben‐Neriah, Sanja Rogić, David W. Scott, King Tan, Christian Steidl, Laurie H. Sehn,

Journal of Clinical Oncology

Abstract

Assessment of MYC and BCL2 expression by IHC represents a robust, rapid, and inexpensive approach to risk-stratify patients with DLBCL at diagnosis.

References

	Year	Citations

Page 1